Curcumin Formulations and Trials: What’s New in Neurological Diseases
Stella Gagliardi(University of Pavia), Cristina Cereda(University of Milan), Davide Prosperi(University of Milano-Bicocca), Veronica Tinelli(Istituti Clinici Scientifici Maugeri), Fabio Corsi(Istituti Clinici Scientifici Maugeri), Miriam A. Hickey(University of Tartu), Cecilia Pandini(University of Pavia), Polychronis Stivaktakis(University of Crete), Carlo Morasso(Istituti Clinici Scientifici Maugeri), Aristides Tsatsakis(University of Crete)
Cited by 46
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
|Nature Genetics|2021|567
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441